Cellebrite DI .(US:CLBT)2024-05-23 16:09Financial Performance - Q1 2024 - Total revenue for Q1 2024 reached $90 million, a 26% increase compared to $71 million in Q1 2023[44, 5] - Subscription revenue for Q1 2024 was $79 million, up 29% from the previous year[25] - ARR (Annual Recurring Revenue) grew by 27% to $332 million as of March 2024, compared to $261 million in March 2023[9, 25] - Adjusted EBITDA for Q1 2024 was $18 million, representing a 20% margin[44] Financial Outlook - The company anticipates revenue between $90 million and $94 million for Q2 2024[87] - The company anticipates revenue between $370 million and $380 million for FY 2024[87] - The company anticipates Adjusted EBITDA between $16 million and $19 million for Q2 2024[87] - The company anticipates Adjusted EBITDA between $70 million and $80 million for FY 2024[87] Additional Metrics - Gross margin for Q1 2024 was 86%[56] - Cash position as of March 31, 2024, was $347.3 million, an increase of $15.5 million from Q4 2023 and $126.1 million from Q1 2023[78] - Gross retention rate is approximately 91%[52]